Quoin Pharmaceuticals (QNRX) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Quoin Pharmaceuticals (QNRX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | 100K | - | - | - | 150K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost Of Revenue | 20K (-33.33%) | 30K | - | 30K (+50.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (+50.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K | - | - | 60K (+100.00%) | 30K | - | - | - | - |
Costof Goods And Services Sold | 20K (-33.33%) | 30K | - | 30K (+50.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (+50.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K | - | - | 60K (+100.00%) | 30K | - | - | - | - |
Gross Profit | -20.00K (-33.33%) | -30.00K | - | -30.00K (+50.00%) | -20.00K | 50K | -30.00K (+50.00%) | -20.00K (-33.33%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K | - | - | -60.00K (+100.00%) | -30.00K | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 3.40M (+9.68%) | 3.10M (+35.96%) | 2.28M (+11.22%) | 2.05M (-13.50%) | 2.37M (+121.50%) | 1.07M (-8.55%) | 1.17M (+98.31%) | 590K (-33.71%) | 890K (+7.23%) | 830K (+9.21%) | 760K (+20.63%) | 630K (-42.20%) | 1.09M (+78.69%) | 610K (-18.67%) | 750K (+2.74%) | 730K (+23.73%) | 590K (-41.58%) | 1.01M (+288.46%) | 260K (+8.33%) | 240K (+300.00%) | 60K (-50.00%) | 120K (+300.00%) | 30K (0.00%) | 30K (-62.50%) | 80K |
Selling General And Administrative | 1.70M (+19.72%) | 1.42M (-18.39%) | 1.74M (0.00%) | 1.74M (+10.13%) | 1.58M (+18.80%) | 1.33M (-2.21%) | 1.36M (-12.26%) | 1.55M (-1.27%) | 1.57M (+12.95%) | 1.39M (+1.46%) | 1.37M (-15.95%) | 1.63M (-2.98%) | 1.68M (+14.29%) | 1.47M (-6.96%) | 1.58M (-18.56%) | 1.94M (+22.01%) | 1.59M (-19.29%) | 1.97M (+89.42%) | 1.04M (+40.54%) | 740K (0.00%) | 740K (+54.17%) | 480K (+60.00%) | 300K (-6.25%) | 320K (0.00%) | 320K |
Operating Expenses | 5.09M (+12.61%) | 4.52M (+12.44%) | 4.02M (+6.07%) | 3.79M (-4.29%) | 3.96M (+64.32%) | 2.41M (-4.74%) | 2.53M (+18.22%) | 2.14M (-13.01%) | 2.46M (+10.81%) | 2.22M (+4.23%) | 2.13M (-5.75%) | 2.26M (-18.71%) | 2.78M (+33.01%) | 2.09M (-10.30%) | 2.33M (-12.73%) | 2.67M (+22.48%) | 2.18M (-26.85%) | 2.98M (+129.23%) | 1.30M (+32.65%) | 980K (+22.50%) | 800K (+35.59%) | 590K (+78.79%) | 330K (-5.71%) | 350K (-12.50%) | 400K |
Depreciation And Amortization | 20K (-33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K | - | 30K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -5.12M (+13.27%) | -4.52M (+12.44%) | -4.02M (+6.07%) | -3.79M (-4.29%) | -3.96M (+64.32%) | -2.41M (-4.74%) | -2.53M (+18.22%) | -2.14M (-13.01%) | -2.46M (+10.81%) | -2.22M (+4.23%) | -2.13M (-5.75%) | -2.26M (-18.71%) | -2.78M (+33.01%) | -2.09M (-10.30%) | -2.33M (-12.73%) | -2.67M (+22.48%) | -2.18M | 2.61M | -1.30M (+32.65%) | -980.00K (+22.50%) | -800.00K (+35.59%) | -590.00K (+78.79%) | -330.00K (-5.71%) | -350.00K (-12.50%) | -400.00K |
Ebit | -4.98M (+14.48%) | -4.35M (+10.13%) | -3.95M (+6.76%) | -3.70M (-2.89%) | -3.81M (+64.94%) | -2.31M (-1.70%) | -2.35M (+19.29%) | -1.97M (-15.45%) | -2.33M (+13.66%) | -2.05M (+6.22%) | -1.93M (-8.53%) | -2.11M (-18.85%) | -2.60M (+30.00%) | -2.00M (-13.79%) | -2.32M (-13.11%) | -2.67M (+58.93%) | -1.68M (-85.05%) | -11.24M (+868.97%) | -1.16M (-71.98%) | -4.14M (+7.81%) | -3.84M (+295.88%) | -970.00K (+193.94%) | -330.00K (-5.71%) | -350.00K (-12.50%) | -400.00K |
EBITDA | -4.96M (+14.81%) | -4.32M (+10.20%) | -3.92M (+6.81%) | -3.67M (-3.17%) | -3.79M (+65.50%) | -2.29M (-1.29%) | -2.32M (+18.97%) | -1.95M (-15.22%) | -2.30M (+13.86%) | -2.02M (+6.32%) | -1.90M (-8.65%) | -2.08M (-19.38%) | -2.58M (+30.96%) | -1.97M (-13.97%) | -2.29M (-13.26%) | -2.64M (+59.04%) | -1.66M (-85.20%) | -11.22M (+892.92%) | -1.13M (-72.51%) | -4.11M (+7.87%) | -3.81M (+301.05%) | -950.00K (+216.67%) | -300.00K (-14.29%) | -350.00K (-5.41%) | -370.00K |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 150K (-11.76%) | 170K (+183.33%) | 60K (-40.00%) | 100K (-28.57%) | 140K (+27.27%) | 110K (-26.67%) | 150K (-11.76%) | 170K (+21.43%) | 140K (-12.50%) | 160K (-20.00%) | 200K (+5.26%) | 190K (+26.67%) | 150K (+87.50%) | 80K (+300.00%) | 20K | - | - | - | - | - | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - | - | - | - | 220K | - | - | 220K (+633.33%) | 30K (-95.77%) | 710K | - | 570K (0.00%) | 570K (+128.00%) | 250K (+25.00%) | 200K (+185.71%) | 70K (+40.00%) | 50K | - | - | - |
Net Interest Income | 150K (-11.76%) | 170K (+183.33%) | 60K (-40.00%) | 100K (-28.57%) | 140K (+27.27%) | 110K (-26.67%) | 150K (-11.76%) | 170K (+21.43%) | 140K (-12.50%) | 160K (-20.00%) | 200K (+5.26%) | 190K (+26.67%) | 150K (+87.50%) | 80K | -700.00K | - | - | -570.00K (+128.00%) | -250.00K (-35.90%) | -390.00K (+143.75%) | -160.00K | - | - | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | -4.98M (+14.48%) | -4.35M (+10.13%) | -3.95M (+6.76%) | -3.70M (-2.89%) | -3.81M (+64.94%) | -2.31M (-1.70%) | -2.35M (+19.29%) | -1.97M (-15.45%) | -2.33M (+13.66%) | -2.05M (+6.22%) | -1.93M (-8.53%) | -2.11M (-18.85%) | -2.60M (+30.00%) | -2.00M (-33.99%) | -3.03M (+13.48%) | -2.67M (+58.93%) | -1.68M (-85.79%) | -11.82M (+744.29%) | -1.40M (-67.74%) | -4.34M (+11.28%) | -3.90M (+282.35%) | -1.02M (+209.09%) | -330.00K (-5.71%) | -350.00K (-12.50%) | -400.00K |
Income Tax Expense | - | - | - | - | - | -1.97M (-99.98%) | -8.95B | 1.97M | - | 2.07M | -20.00K (-89.47%) | -190.00K (-13.64%) | -220.00K (+633.33%) | -30.00K | 710K | - | -490.00K (-93.63%) | -7.69M | 390K | -2.77M (+544.19%) | -430.00K (+1333.33%) | -30.00K | - | - | - |
Net Income From Continuing Operations | -5.00M (+14.94%) | -4.35M (+10.13%) | -3.95M (+6.76%) | -3.70M (-2.89%) | -3.81M (+64.94%) | -2.31M (-1.70%) | -2.35M (+19.29%) | -1.97M (-15.45%) | -2.33M (+13.66%) | -2.05M (+6.22%) | -1.93M (-8.53%) | -2.11M (-18.85%) | -2.60M (+30.00%) | -2.00M (-33.99%) | -3.03M (+13.48%) | -2.67M (+58.93%) | -1.68M (-85.79%) | -11.82M (+744.29%) | -1.40M (-67.74%) | -4.34M (+11.28%) | -3.90M | - | - | - | - |
Net Income | -4.98M (+14.48%) | -4.35M (+10.13%) | -3.95M (+6.76%) | -3.70M (-2.89%) | -3.81M (+64.94%) | -2.31M (-1.70%) | -2.35M (+19.29%) | -1.97M (-15.45%) | -2.33M (+13.66%) | -2.05M (+6.22%) | -1.93M (-8.53%) | -2.11M (-18.85%) | -2.60M (+30.00%) | -2.00M (-33.99%) | -3.03M (+13.48%) | -2.67M (+58.93%) | -1.68M (-85.79%) | -11.82M (+744.29%) | -1.40M (-67.74%) | -4.34M (+11.28%) | -3.90M (+282.35%) | -1.02M (+209.09%) | -330.00K (-5.71%) | -350.00K (-12.50%) | -400.00K |